Answer
Women of childbearing potential should use effective contraception throughout toripalimab treatment and for at least 4 months after the last dose.
Sources for this answer
- LOQTORZI 240 mg concentrate for solution for infusionTopalliance Biosciences Europe Limited · emc · SmPC §4.6 Fertility, pregnancy and lactation · Version 1Document updated
Sources checked